Cardama Alfonso Quintas

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value
2022-12-13	2022-12-13	TCR2 Therapeutics Inc (TCRR)	PlS Planned sale	92,995 +2.9% 414.65 US$974,485	92,995 +2.9%	414.65	US$974,485
2022-12-13	2022-12-12	TCR2 Therapeutics Inc (TCRR)	PlS Planned sale	280 -1.3% 122.76 US$793,515	280 -1.3%	122.76	US$793,515
2022-12-13	2022-12-09	TCR2 Therapeutics Inc (TCRR)	PlS Planned sale	72,985 +31.2% 394.22 US$3,189,389	72,985 +31.2%	394.22	US$3,189,389
2022-12-09	2022-12-08	TCR2 Therapeutics Inc (TCRR)	PlS Planned sale	4,014 -3.2% 1.26 US$5,042	4,014 -3.2%	1.26	US$5,042
2022-12-09	2022-12-07	TCR2 Therapeutics Inc (TCRR)	PlS Planned sale	3,928 -3.0% 1.28 US$5,040	3,928 -3.0%	1.28	US$5,040
2022-12-07	2022-12-06	TCR2 Therapeutics Inc (TCRR)	PlS Planned sale	3,778 -2.8% 1.33 US$5,040	3,778 -2.8%	1.33	US$5,040
2022-12-07	2022-12-05	TCR2 Therapeutics Inc (TCRR)	PlS Planned sale	3,686 -2.7% 1.37 US$5,050	3,686 -2.7%	1.37	US$5,050
2022-12-05	2022-12-02	TCR2 Therapeutics Inc (TCRR)	PlS Planned sale	3,636 -2.6% 1.39 US$5,054	3,636 -2.6%	1.39	US$5,054